The volume in Central Massachusetts ERs is still expected to grow, exacerbated by a primary care shortage and incoming $1 trillion in cuts nationally to Medicaid.
A month after seven Worcester representatives signed a letter urging UMass Chan Medical School to increase physician wages, the Worcester university has reached a tentative contract agreement with the physician union representing 700 UMass providers.
Central Massachusetts’ largest hospital, UMass Memorial Medical Center in Worcester, has named its new chief of cardiac surgery, selecting a physician from England to fill the role.
Insulet, the Acton-based medical device manufacturer and public company, has named a former global chair at multinational bank JPMorgan Chase to its board of directors.
Medical device manufacturer Hologic is going from a publicly traded company to a private business as the Marlborough-based firm is to be acquired for up to $18.3 billion.
Throughout Central Mass., healthcare organizations, nonprofit leaders, and practitioners are working to combat a startling and unsettling rise in medical misinformation and disinformation.
UMass Chan Medical School in Worcester could receive up to $18 million from the U.S. Department of Defense to lead a nationwide clinical study to determine if metformin, a drug used to treat high blood sugar and type 2 diabetes, can be used to treat a form of chronic, progressive lung disease.
Boston Scientific, a Marlborough medical device manufacturer, has entered into yet another half-billion-dollar purchase agreement, this time to acquire Nalu Medical, a California-based medical technology firm creating solutions for chronic nerve pain.